In particular, infants carrying CT or TT genotype of CCL2 rs13900 were statistically more likely to develop SNHL compared to infants with CC genotype (OR = 3.38; 95% CI, 1.06–10.74, p = 0.033 and OR = 4.0, 95% CI: 1.01–15.87, p = 0.04, for hearing status at birth and at the age of 6 months, respectively). Here, CCL2 is linked to sensorineural hearing loss disorder.